The Interim Analysis of a Single-Arm, Open-Label, Phase II Study Investigating ALLEN Regimen (durvalumab Plus Albumin Paclitaxel and Lenvatinib) in Patients with Metastatic Pancreatic Cancer (Mpc).
Journal of Clinical Oncology（2024）
Key words
283-237-267,261-492-3532-2370-7650-2700,261-492-3532-2370-5109,261-492-2769,283-2494-7461,613-225-2575-3984,261-566-9690,28,2018,2018,28,38116-38094-8,38092-20072
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined